Bob Tambo has created the event’s logo for 14 years. This weekend, he’ll take part in the 2-mile walk to celebrate his recovery.

Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer's disease (AD). TML-6 combines ...